Texan Capital Management’s AbbVie ABBV Stock Holding History

Texan Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$773K	Hold	7,988	–	–	0.5%	59
2017 Q3	$710K	Sell	7,988 -183	-2%	-$13.9K	0.47%	60
2017 Q2	$592K	Hold	8,171	–	–	0.4%	61
2017 Q1	$532K	Hold	8,171	–	–	0.24%	93
2016 Q4	$512K	Buy	+8,171	New	+$499K	0.24%	97
2016 Q3	–	Sell	-8,312	Closed	-$515K	–	128
2016 Q2	$515K	Buy	8,312 +33	+0.4%	+$2.01K	0.24%	99
2016 Q1	$472K	Buy	8,279 +51	+0.6%	+$2.84K	0.22%	99
2015 Q4	$487K	Hold	8,228	–	–	0.22%	97
2015 Q3	$448K	Hold	8,228	–	–	0.2%	109
2015 Q2	$553K	Buy	8,228 +183	+2%	+$11.9K	0.22%	102
2015 Q1	$471K	Hold	8,045	–	–	0.26%	84
2014 Q4	$526K	Hold	8,045	–	–	0.23%	86
2014 Q3	$465K	Sell	8,045 -1,100	-12%	-$61.1K	0.2%	93
2014 Q2	$516K	Hold	9,145	–	–	0.22%	96
2014 Q1	$470K	Hold	9,145	–	–	0.22%	101
2013 Q4	$483K	Hold	9,145	–	–	0.25%	94
2013 Q3	$409K	Hold	9,145	–	–	0.2%	113
2013 Q2	$378K	Buy	+9,145	New	+$400K	0.18%	115

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Texan Capital Management's ABBV Position: Q4 2017 in Review

Texan Capital Management held its AbbVie (ABBV) position steady in Q4 2017 at 7,988 shares worth $773K. The position accounts for 0.5% of the portfolio, ranked #59.

Texan Capital Management first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

Texan Capital Management held 7,988 shares of AbbVie worth $773K as of Q4 2017.
Texan Capital Management left its AbbVie share count unchanged in Q4 2017.
AbbVie made up 0.5% of Texan Capital Management's portfolio in Q4 2017, its #59 holding.
Texan Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Texan Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.